The Patent Finder

Biocon Limited

65 patents currently held · Updated Nov 22, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
24
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 14 to 28, 2027 · next Jan 14
  • 3 fees due Feb 11 to 20, 2027 · next Feb 11
  • 1 fee due Apr 29, 2027
    The maintenance fee for Crystalline Forms of Posaconazole Intermediate and Process for the Preparation of Amorphous Posaconazole (US 10,457,668) comes due Apr 29, 2027. Unpaid by Oct 29, 2027, it lapses early.
  • 1 fee due Jun 22, 2027
    The maintenance fee for Monoclonal Antibody and a Method Thereof (US 9,217,037) comes due Jun 22, 2027. Unpaid by Dec 22, 2027, it lapses early.
  • 2 fees due Jul 7 to 26, 2027 · next Jul 7
  • 1 fee due Aug 9, 2027
    The maintenance fee for Fermentation medias and processes thereof (US 9,255,285) comes due Aug 9, 2027. Unpaid by Feb 9, 2028, it lapses early.
  • 2 fees due Nov 14 to 17, 2027 · next Nov 14

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,329,958Combinatorial synthesis of PEG oligomer libraries
In force
 · USPTO record
In forceUSPTO record
US 8,563,685Fatty acid formulations and oral delivery of proteins and peptides, and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,058,391Process for the preparation of insulin conjugate IN-105
In force
 · USPTO record
In forceUSPTO record
US 7,872,095Insulin-oligomer conjugates, formulations and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 7,875,700Cation complexes of insulin compound conjugates, formulation and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 7,932,366Synthesis of azo bonded immunoregulatory compounds
In force
 · USPTO record
In forceUSPTO record
US 9,101,596Cation complexes of insulin compound conjugates, formulations and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 8,802,816Method of obtaining a purified, biologically active heterologous protein
In force
 · USPTO record
In forceUSPTO record
US 9,102,758Insulin-oligomer conjugates, formulations and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 9,670,285Monoclonal Antibody and a Method Thereof
In force
 · High confidence
In forceHigh confidence
10 of 65 patents shown.
Pro members see all 65.
Pro members: see all 65 patents
Also on record, not counted in the 65: 50 lapsed for an unpaid fee · 47 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 6 abandoned · 15 no status recorded

Showing 1 to 10 of 30, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
19/236,781Jun 12, 2025No status recorded
18/746,907Targeted/Immunomodulatory Fusion Proteins and Methods for Making SameJun 18, 2024Pending
18/630,519Monoclonal Antibody and a Method ThereofApr 9, 2024Pending
18/335,542Use of Itolizumab to Reduce Phosphorylation of CD6Jun 15, 2023Pending
18/199,675Formulations of AntibodyMay 19, 2023Pending
18/689,550Preparation Method of Echinocandin NucleusSep 7, 2022Pending
18/682,254Purification of LiraglutideAug 9, 2022Pending
18/283,281Process for Preparation of CabozantinibMar 24, 2022Pending
18/270,520Synthesis of TeduglutideJan 3, 2022Pending
17/559,382Monoclonal Antibody and a Method of Use for the Treatment of LupusDec 22, 2021Abandoned
10 of 30 applications shown.
Pro members see all 30 published applications.
Pro members: see all 30 applications
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited